DCEP regimen buys time for multiple myeloma patients
|
Dr George Grigoriadis |
The combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin (DCEP) is an effective bridge to autologous stem cell transplant (ASCT) or novel agents in patients with relapsed refractory multiple myeloma.
Original story in The Limbic.
No comments:
Post a Comment